JG
GHDX

Jefferies Group’s Genomic Health, Inc. GHDX Stock Holding History

Jefferies Group’s Portfolio GHDX Stock Details GHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6,350
Closed -$445K – 3044
2019
Q1 		$445K Buy
+6,350
New +$471K ﹤0.01% 1645
2017
Q4 		– Sell
-11,417
Closed -$366K – 2960
2017
Q3 		$366K Buy
+11,417
New +$360K ﹤0.01% 1790

Other funds holding GHDX

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jefferies Group's GHDX Position: Q2 2019 in Review

Jefferies Group sold out of Genomic Health, Inc. (GHDX) in Q2 2019, closing a stake of 6,350 shares — an estimated $445K sold.

Jefferies Group first reported a position in GHDX in Q3 2017 and held it in 2 quarters. The position peaked at $445K in Q1 2019. 215 funds tracked by Wall St. Rank hold GHDX as of Q2 2019.

  • Jefferies Group reported no remaining Genomic Health, Inc. position as of Q2 2019 after selling out during the quarter.
  • Jefferies Group sold 6,350 Genomic Health, Inc. shares in Q2 2019, an estimated $445K.
  • Jefferies Group first reported a position in Genomic Health, Inc. in Q3 2017 and held it in 2 quarters.
  • Jefferies Group's Genomic Health, Inc. position peaked at $445K in Q1 2019.
  • 215 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q2 2019.

Based on Jefferies Group's 13F filing for Q2 2019, filed 14 Aug 2019.